Blackstone to buy BioMed Realty for $8 bln
The Blackstone Group has agreed to buy BioMed Realty Trust Inc. for $23.75 a share or $8 billion. Biomed owns office buildings that cater to life science tenants in Boston-Cambridge, San Francisco, San Diego and Seattle. The deal is expected to close in first quarter 2016.





